Nebenwirkungen · Pramipexole Teva
Pramipexole Teva 0.088 mg tablets Pramipexole Teva 0.18 mg tablets Pramipexole Teva 0.35 mg tablets Pramipexole Teva 0.7 mg tablets · Abschnitt 4.8 · PDF-Seite 8–9
HOS-119869 · Präparat HOS-095037
8 Nervous somnolence headache sudden onset of system dizziness sleep disorders dyskinesia amnesia hyperkinesia syncope Eye disorders visual impairment including diplopia vision blurred visual acuity reduced Cardiac cardiac failure1 disorders Vascular hypotension disorders Respiratory, dyspnoea thoracic, and hiccups mediastinal disorders Gastrointestinal nausea constipation disorders vomiting Skin and hypersensitivity subcutaneous pruritus tissue disorders rash Reproductive spontaneous system and penile breast disorders erection General fatigue dopamine disorders and peripheral agonist administration oedema withdrawal site conditions syndrome including apathy, anxiety, depression, fatigue, sweating and pain. Investigations weight decrease weight increase including decreased appetite 1 This side effect has been observed in post-marketing experience. With 95 % certainty, the frequency category is not greater than uncommon, but might be lower. A precise frequency estimation is not possible as the side effect did not occur in a clinical trial database of 2 762 patients with Parkinson’s Disease treated with pramipexole.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-09-02T17:36:00Z · SHA-256 5d166932f43f2c779defb4b949fcb54f71a25cc3c96586af3caa034b7968230d · Passage 7a7925caf7f6ffab1aa943ce5a96ab180d1a50ccc10dc0fdef33f76081d7a47c · Zeichen 3020–6202 im Abschnitt